Jason Laskey
Impact in
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Prostate Cancer Treatment and Research
Papers in
- Oncology 3
- Peptidase Inhibition and Analysis 2
- Cancer Immunotherapy and Biomarkers 2
-
- T-cell and B-cell Immunology 1
- Immunotherapy and Immune Responses 1
- Co-authors
- Joe Jiang Zhu (1 shared paper)Chris Ware (1 shared paper)Minilik Angagaw (2 shared papers)Clay L. Efferson (1 shared paper)Weisheng Zhang (1 shared paper)Shailaja Kasibhatla (1 shared paper)Cyrille Sur (1 shared paper)John F. Reilly (1 shared paper)
- Journals
- Journal for ImmunoTherapy of Cancer (1 paper)PLoS ONE (1 paper)Cancer Research (1 paper)Oncotarget (1 paper)
- Partner nations
- United States
In The Last Decade
Jason Laskey
4 papers receiving 103 citations
Peers
Comparison fields: 5 of 32
- Oncology 37
- Pulmonary and Respiratory Medicine 44
- Cancer Research 20
- Molecular Biology 79
- Immunology 20
Countries citing papers authored by Jason Laskey
This map shows the geographic impact of Jason Laskey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Laskey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Laskey more than expected).
Fields of papers citing papers by Jason Laskey
This network shows the impact of papers produced by Jason Laskey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Laskey. The network helps show where Jason Laskey may publish in the future.
Co-authors
The 25 scholars most cited alongside Jason Laskey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 66 | |
| 2 | 2020 | 29 | |
| 3 | 2018 | 8 | |
| 4 | 2015 | 6 |
About Jason Laskey
Jason Laskey is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 4 papers that have together received 109 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Prostate Cancer Treatment and Research (1 paper), T-cell and B-cell Immunology (1 paper), PI3K/AKT/mTOR signaling in cancer (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Oncology (37 citations), Pulmonary and Respiratory Medicine (44 citations), Cancer Research (20 citations), Molecular Biology (79 citations) and Immunology (20 citations). Jason Laskey has collaborated with scholars based in United States. Frequent co-authors include Joe Jiang Zhu, Chris Ware, Minilik Angagaw, Clay L. Efferson, Weisheng Zhang, Shailaja Kasibhatla, Cyrille Sur, John F. Reilly, Pradip K. Majumder and Jennifer Tammam. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, PLoS ONE, Cancer Research and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.